Exchange: NASDAQ·Updated 06:20 PM EDT

About LNAI

About

Lunai Bioworks, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev and Serhat Gumrukcu on January 18, 2011 and is headquartered in Sacramento, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
12

Frequently Asked Questions

What is Market Cap of Lunai Bioworks Inc.?
What is the 52-week high for Lunai Bioworks Inc.?
What is the 52-week low for Lunai Bioworks Inc.?
What is Lunai Bioworks Inc. stock price today?
What is the PE ratio of Lunai Bioworks Inc.?
What is the Price-to-Book ratio of Lunai Bioworks Inc.?
What is the 50-day moving average of Lunai Bioworks Inc.?
How many employees does Lunai Bioworks Inc. have?

Advertisement|Remove ads.